Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Catabasis Pharmaceuticals Inc buy melinda

Start price
€67.65
02.02.17 / 50%
Target price
€108.24
10.03.17
Performance (%)
68.84%
End price
€114.22
10.03.17
Summary
This prediction ended on 10.03.17 with a price of €114.22. The BUY prediction by melinda for Catabasis Pharmaceuticals Inc saw massive gains of 68.84%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Catabasis Pharmaceuticals Inc - - - -
iShares Core DAX® -0.268% 5.471% 14.271% 19.027%
iShares Nasdaq 100 1.854% 7.851% 35.426% 58.415%
iShares Nikkei 225® 0.284% 1.729% 9.943% 7.045%
iShares S&P 500 1.178% 5.269% 27.989% 49.400%

Comments by melinda for this prediction

In the thread Catabasis Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 68.84%
Target price 18.040
Change
Ends at 10.03.17

folgen

noch zurückkehren

Prediction Buy
Perf. (%) 68.84%
Target price 18.040
Change
Ends at 10.03.17

(Zielkurs erreicht)

Stopped prediction by melinda for Catabasis Pharmaceuticals Inc

buy
Catabasis Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€8.84
27.10.20
€15.00
04.11.21
-20.00%
05.11.21

buy
Catabasis Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€29.28
03.03.20
€33.00
27.10.20
-69.82%
27.10.20

buy
Catabasis Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€188.33
04.10.17
€270.60
19.12.17
-53.02%
19.12.17

buy
Catabasis Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€188.34
16.12.16
€216.48
22.12.16
18.10%
22.12.16

buy
Catabasis Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€196.46
10.07.16
€270.60
04.08.16
39.97%
04.08.16